Michael Kauffman Karyopharm Therapeutics Inc. (KPTI) insider trading activity

Michael Kauffman is Director of Karyopharm Therapeutics Inc.. Currently has a direct ownership of 713,757 shares of KPTI, which is worth approximately $456,804. The most recent transaction as insider was on Feb 28, 2022, when has been sold 6,226 shares (Common Stock) at a price of $10.24 per share, resulting in proceeds of $63,754. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 714K

0% 3M change

0% 12M change

Total Value Held $456,804

Michael Kauffman Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Feb 28 2022	SELL Open market or private sale	$63,754 $10.24 p/Share	6,226 Reduced 0.86%	713,757 Common Stock
Feb 28 2022	BUY Grant, award, or other acquisition	-	21,000 Added 2.83%	719,983 Common Stock
Feb 17 2022	SELL Open market or private sale	$110,037 $12.12 p/Share	9,079 Reduced 1.28%	698,983 Common Stock
Feb 07 2022	SELL Open market or private sale	$66,693 $9.86 p/Share	6,764 Reduced 0.95%	708,062 Common Stock
Mar 18 2021	SELL Open market or private sale	$49,560 $12.39 p/Share	4,000 Reduced 0.56%	714,826 Common Stock
Feb 25 2021	BUY Grant, award, or other acquisition	-	57,200 Added 7.37%	718,826 Common Stock
Feb 18 2021	SELL Open market or private sale	$140,811 $14.83 p/Share	9,495 Reduced 1.62%	575,126 Common Stock
Feb 15 2021	BUY Exercise of conversion of derivative security	-	21,800 Added 3.59%	584,621 Common Stock
Feb 11 2021	SELL Open market or private sale	$102,448 $15.52 p/Share	6,601 Reduced 1.16%	562,821 Common Stock
Feb 05 2021	BUY Exercise of conversion of derivative security	-	14,300 Added 2.45%	569,422 Common Stock

Also insider at

ACET

Adicet Bio, Inc. Healthcare

KZR

Kezar Life Sciences, Inc. Healthcare

VSTM

Verastem, Inc. Healthcare

Director